ScienceMakers Toolkit Manual - The History Makers
ScienceMakers Toolkit Manual - The History Makers
ScienceMakers Toolkit Manual - The History Makers
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Science<strong>Makers</strong></strong><br />
Spotlight: Shawna Nesbitt<br />
Full Name: Shawna Denise Nesbitt<br />
Born: November 10, 1963<br />
Place: Aliquippa, PA<br />
Parents: Yvonne Sarvis Smith<br />
Townsend Smith, Jr.<br />
Spouse: Thomas Nesbitt<br />
Education: Quigley High School – Pittsburgh, PA (1981)<br />
Gannon University – Erie, PA (B.S. Medicine, 1984)<br />
Hahnemann University School of Medicine – Philadelphia, PA (M.D.,<br />
1988)<br />
Type of Science: Cardiovascular Physics<br />
Achievements: Initiated the trial of preventing hypertension in patients with high blood<br />
pressure<br />
Awarded for her work on cardiovascular epidemiology and high blood<br />
pressure by the American Heart Association<br />
Biography<br />
Dr. Shawna Denise Nesbitt was born on November 10, 1963 in Aliquippa, Pennsylvania.<br />
Nesbitt attended Quigley High School in Pittsburgh, Pennsylvania. After graduating, she enrolled<br />
at Gannon University in Erie, Pennsylvania, where she graduated cum laude with her B.S. degree<br />
from the university’s seven-year accelerated medicine program in 1984. Nesbitt then attended Hahnemann<br />
University School of Medicine in Philadelphia, Pennsylvania, where she earned her M.D.<br />
degree in 1988. Nesbitt completed her internship and residency in internal medicine at Allegheny<br />
General Hospital in Pittsburgh in 1991, and became a fellow in hypertension at the University of<br />
Michigan’s Department of Internal Medicine in Ann Arbor, Michigan.<br />
Nesbitt was hired by the University of Michigan Medical School, where she served as an instructor<br />
and then lecturer for the university’s Department of Internal Medicine during the 1990s. Nesbitt<br />
went on to work as an investigator for various fi rms, performing research on African Americans<br />
with hypertension and renal disease, and also on the effects of quinapril on insulin resistant humans.<br />
In 1995, Nesbitt was hired by Merck & Company, Inc. to conduct a LIFE study on individuals with<br />
left ventricular hypertrophy. In 1996, Nesbitt worked for the American Heart Association as a coinvestigator<br />
for a study on individuals with heterozygous familial hypercholesterolemia. Nesbitt<br />
99